Oxycodone
- Generic Name
- Oxycodone
- Brand Names
- Endocet, Endodan Reformulated May 2009, Nalocet, Oxaydo, Oxy.IR, Oxycontin, Oxyneo, Percocet, Prolate, Rivacocet, Roxicet, Roxicodone, Roxybond, Targin, Targiniq, Xolox, Xtampza
- Drug Type
- Small Molecule
- Chemical Formula
- C18H21NO4
- CAS Number
- 76-42-6
- Unique Ingredient Identifier
- CD35PMG570
- Background
Oxycodone is a semisynthetic opioid analgesic derived from thebaine in Germany in 1917. It is currently indicated as an immediate release product for moderate to severe pain and as an extended release product for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period. The first oxycodone containing product, Percodan, wa...
- Indication
Oxycodone is indicated for the treatment of moderate to severe pain. There is also an extended release formulation indicated for chronic moderate to severe pain requiring continuous opioid analgesics for an extended period.
- Associated Conditions
- Severe Acute Pain, Severe Pain, Severe, Chronic Pain, Acute, moderate Pain, Chronic, moderate Pain
- Associated Therapies
- -
Clinical Evaluation of the ReLeaf Analgesic Infusion Catheter & Wound Drain
- Conditions
- Interventions
- First Posted Date
- 2014-11-18
- Last Posted Date
- 2016-01-22
- Lead Sponsor
- Vital 5, LLC
- Registration Number
- NCT02293525
A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users
- Conditions
- Interventions
- First Posted Date
- 2014-08-15
- Last Posted Date
- 2014-12-02
- Lead Sponsor
- Alkermes, Inc.
- Target Recruit Count
- 59
- Registration Number
- NCT02218021
- Locations
- 🇺🇸
Alkermes Investigational Site, Overland Park, Kansas, United States
Effects of Ethanol on Oxycodone Pharmacokinetics in Healthy Volunteers
- First Posted Date
- 2014-06-18
- Last Posted Date
- 2016-04-04
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 17
- Registration Number
- NCT02165930
- Locations
- 🇺🇸
Pfizer Investigational Site, Overland Park, Kansas, United States
Effect of a Multimodal Pain Regimen on Pain Control, Patient Satisfaction and Narcotic Use in Orthopaedic Trauma Patients
- Conditions
- Interventions
- First Posted Date
- 2014-06-10
- Last Posted Date
- 2017-05-19
- Lead Sponsor
- University of North Carolina, Chapel Hill
- Registration Number
- NCT02160301
- Locations
- 🇺🇸
UNC Chapel Hill Hospital, Chapel Hill, North Carolina, United States
Analgesic Response to Opioid Analgesics in Buprenorphine-Maintained Individuals
- First Posted Date
- 2014-05-13
- Last Posted Date
- 2014-05-13
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 12
- Registration Number
- NCT02136784
- Locations
- 🇺🇸
UCLA Integrated Substance Abuse Programs Outpatient Clinical Research Center, Los Angeles, California, United States
Effects of Food on Oxycodone Pharmacokinetics in Healthy Volunteers
- First Posted Date
- 2014-04-21
- Last Posted Date
- 2016-04-04
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 34
- Registration Number
- NCT02117583
- Locations
- 🇺🇸
Pfizer Investigational Site, Overland Park, Kansas, United States
Decreasing Narcotics in Advanced Pelvic Surgery
- First Posted Date
- 2014-04-10
- Last Posted Date
- 2016-08-17
- Lead Sponsor
- Hartford Hospital
- Target Recruit Count
- 138
- Registration Number
- NCT02110719
- Locations
- 🇺🇸
Hartford Hosptial, Hartford, Connecticut, United States
A Comparison of Targinact vs. Oxycodone on Gut Function After Colorectal Surgery
- Conditions
- Interventions
- First Posted Date
- 2014-04-10
- Last Posted Date
- 2017-03-29
- Lead Sponsor
- University of Edinburgh
- Target Recruit Count
- 50
- Registration Number
- NCT02109640
- Locations
- 🇬🇧
Western General Hospital, Edinburgh, United Kingdom
Dose Proportionality Study Of PF-00345439 Formulation Under Fed Conditions
- First Posted Date
- 2014-03-17
- Last Posted Date
- 2016-04-04
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 18
- Registration Number
- NCT02089295
- Locations
- 🇺🇸
Pfizer Investigational Site, Overland Park, Kansas, United States
Single-Dose, Crossover Study To Compare Bioavailability Of Two Formulations Under Fed And Fasted Conditions
- First Posted Date
- 2014-02-11
- Last Posted Date
- 2016-04-04
- Lead Sponsor
- Pain Therapeutics
- Target Recruit Count
- 134
- Registration Number
- NCT02059915
- Locations
- 🇺🇸
Pfizer Investigational Site, St. Paul, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.